Download PDF
Digestive Disease Interventions 2019; 03(02): 133-137
DOI: 10.1055/s-0039-1688437
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA

Radiofrequency Ablation of Pancreatic Cancer

Alessandro Sarno
1   Department of Radiology, G.B. Rossi Hospital, University of Verona, Verona, Italy
,
Alessandro Beleù
1   Department of Radiology, G.B. Rossi Hospital, University of Verona, Verona, Italy
,
Riccardo De Robertis
2   Department of Radiology, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy
,
Gabriele Giannotti
1   Department of Radiology, G.B. Rossi Hospital, University of Verona, Verona, Italy
,
Giorgia Tedesco
1   Department of Radiology, G.B. Rossi Hospital, University of Verona, Verona, Italy
,
Salvatore Paiella
3   Department of Surgery, G.B. Rossi Hospital, University of Verona, Verona, Italy
,
Mirko D'Onofrio
1   Department of Radiology, G.B. Rossi Hospital, University of Verona, Verona, Italy
› Author Affiliations
Further Information

Publication History

03 December 2018

12 March 2019

Publication Date:
10 May 2019 (online)

Also available at
   Buy Article Permissions and Reprints
Zoom Image

Abstract

Radiofrequency ablation (RFA) is emerging as a safe and feasible technique to treat various pancreatic lesions. In particular, pancreatic ductal adenocarcinoma (PDAC) is the most frequent treated lesion. Nowadays, PDAC treatment by means of RFA is limited to locally advanced, non-resectable, but non-metastatic lesions. The aim of this article is to describe the RFA technique, its results and possible complications.

Keywords

pancreas - radiofrequency ablation - pancreatic adenocarcinoma